Armata Pharmaceuticals (ARMP) Other Non Operating Income (2013 - 2026)

Armata Pharmaceuticals has disclosed Other Non Operating Income across 14 years of filings, most recently posting -$101.1 million for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$101.1 million, down 2044.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$119.8 million (down 314.52% YoY), and the FY2025 annual result was $388000.0, down 98.35% from the prior year.
• Other Non Operating Income came in at -$101.1 million for Q1 2026 at Armata Pharmaceuticals, down from $131000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $23.4 million in Q2 2024 to a low of -$101.1 million in Q1 2026.
• The 5-year median for Other Non Operating Income is $9000.0 (2022), against an average of -$6.0 million.
• Peak annual rise in Other Non Operating Income reached 120620.0% in 2023, while the deepest fall reached 314500.0% in 2023.
• Armata Pharmaceuticals' Other Non Operating Income stood at $14000.0 in 2022, then slumped by 168671.43% to -$23.6 million in 2023, then surged by 197.26% to $23.0 million in 2024, then slumped by 99.43% to $131000.0 in 2025, then slumped by 77275.57% to -$101.1 million in 2026.
• The last three Other Non Operating Income figures came in at -$101.1 million (Q1 2026), $131000.0 (Q4 2025), and -$18.9 million (Q3 2025), per Business Quant data.